PRO-MERIT

· BioNTech SE

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PRO-MERIT, covering 2025-03-20 to 2025-03-20. Get the full timeline:

Most recent: Clinical Trial Update: PRO-MERIT (Prostate Cancer Messenger RNA Immunotherapy) [Phase 1, Phase 2]